Insulin Detemir clinical trials
Also written Levemir and Detemir.
How each study uses Insulin Detemir is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Insulin Detemir studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 16 Jun 2005 · LEVEMIR FLEXTOUCH · BLA 021536 (FDA, Drugs@FDA)
- European Union
- 1 Jun 2004 · Levemir · EMEA/H/C/000528 (EMA)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
96 studies that test it; most in 2008 (14)
| Year | Studies |
|---|---|
| 1999 | 1 |
| 2001 | 2 |
| 2002 | 4 |
| 2003 | 7 |
| 2004 | 11 |
| 2005 | 13 |
| 2006 | 8 |
| 2007 | 10 |
| 2008 | 14 |
| 2009 | 6 |
| 2010 | 5 |
| 2011 | 6 |
| 2012 | 4 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2021 | 1 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 61 · Other 36
Novo Nordisk A/S (58) · Diabetes Care Center (2) · University of Aarhus (2) · University of Texas Southwestern Medical Center (2) · The Royal Bournemouth Hospital (2) · Vanderbilt University (1) · University of Surrey (1) · Sydney Children's Hospitals Network (1)
Often tested with
Tested in the same studies.
Insulin Aspart (20) · Insulin Glargine (15) · Insulin, Isophane (10) · Isophane Insulin, Human (2) · Insulin, Regular, Human (2) · Liraglutide (2) · Insulin aspart, insulin aspart protamine drug combination 30:70 (2) · NNC0363-0845 (1)
Related medicines
As reviewed, each with the page that says it.
- One of Hypoglycemic Agents source
Studies
Open first, then newest update. How each study uses Insulin Detemir is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 97
- DETERMINE: Detemir vs NPHRecruitingPhase 2University of California, Los AngelesNCT05124457Written as Insulin DetemirHow we know
- Insulin Detemir in Obesity ManagementActive, not recruitingNot applicableVanderbilt UniversityNCT01239550Written as DetemirHow we know
- The Impact of Insulin Therapy on Protein Turnover in Pre-Diabetic Cystic Fibrosis PatientsTerminatedPhase 2/3University of MinnesotaNCT02496780Written as levemir insulinHow we know
- Treatment With Continuous Sub-cutaneous Insulin Infusion Via a Portable Pump Versus Discontinuous Insulin Infusion Via Multiple-injections in Type 2 DiabetesTerminatedPhase 4Centre Hospitalier Universitaire DijonNCT02048189Written as LEVEMIRHow we know
- Evaluation of the Glycaemic Control With Insulin Detemir as an add-on to Current Oral Anti-diabetic Drug Treatment in Subjects With Type 2 Diabetes in KoreaCompletedPhase 4Novo Nordisk A/SNCT00455858Written as insulin detemirHow we know
- Safety of Insulin Detemir Produced by a New Process as Measured by Antibody Formation in Subjects With Type 1 DiabetesCompletedPhase 3Novo Nordisk A/SNCT00447382Written as insulin detemirHow we know
- Effect of Insulin Detemir on Blood Glucose Control in Subjects With Type 2 DiabetesCompletedPhase 3Novo Nordisk A/SNCT00383877Written as insulin detemirHow we know
- Comparison of Insulin Detemir Versus Insulin NPH on Weight Change in Overweight and Obese With Type 2 DiabetesCompletedPhase 3Novo Nordisk A/SNCT00504673Written as insulin detemirHow we know
- The Effect of Insulin Detemir on Blood Glucose Control in Taiwanese Patients With Type 2 Diabetes Failing on OADCompletedPhase 4Novo Nordisk A/SNCT00521690Written as insulin detemirHow we know
- The Effect of Exercise on Blood Glucose Levels in Patients With Type 1 Diabetes: A Comparison of 3 Long-acting InsulinsCompletedPhase 4Novo Nordisk A/SNCT00313742Written as insulin detemirHow we know
- Comparison of Insulin Detemir and NPH Insulin Given Once Daily in Ageing Subjects With Type 2 DiabetesTerminatedPhase 4Novo Nordisk A/SNCT00506662Written as insulin detemirHow we know
- Detemir Energy Expenditure StudyCompletedPhase 4University of SurreyNCT00788840Written as DetemirHow we know
- Cystic Fibrosis - Insulin Deficiency, Early ActionCompletedPhase 3Sydney Children's Hospitals NetworkNCT01100892Written as Once-daily insulin detemirHow we know
- A Multiple Dose Study Investigating Pharmacokinetics and Pharmacodynamics of Subcutaneous NNC0363-0845 in Participants With Type 1 Diabetes Pharmacokinetics and Pharmacodynamics: How Insulin NNC0363-0845 is Transported Throughout the Body and How It WorksCompletedPhase 1Novo Nordisk A/SNCT05134987Written as Insulin detemirHow we know
- Management of Diabetes in the Emergency Room: a Randomized Trial of an Insulin Protocol.CompletedPhase 4Rush University Medical CenterNCT00591227Written as insulin detemirHow we know
- Effectiveness of Adding Subcutaneous Long-Acting Detemir to Insulin Drip Therapy Compared With Standard Insulin Drip TherapyCompletedNot applicableUniversity of Colorado, DenverNCT01186003Written as DetemirHow we know
- Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 120 Days (SL120)CompletedPhase 2Wake Forest University Health SciencesNCT01595646Written as Insulin detemirHow we know
- Duration of The Honeymoon Phase of Type 1 Diabetes: A Comparison of Insulins Detemir, Glargine and NPHTerminatedNot applicableUniversity of Texas Southwestern Medical CenterNCT00564018Written as Insulin detemirHow we know
- Evaluation of Glycemic Changes During Exercise in Children With Type 1 DiabetesCompletedNot applicableCliniques universitaires Saint-Luc- Université Catholique de LouvainNCT02824510Written as Insulin aspart, glargine and detemirHow we know
- Cooperation of Insulin and GLP-1 on Myocardial Glucose UptakeCompletedNot applicableIndiana UniversityNCT01232946Written as insulin detemirHow we know
See all 97 studies that test Insulin Detemir →
Given beside what is tested · 11 — Insulin Detemir is usual care or a partner of the new treatment
- MeDiGes Study: Metformine Use in Gestational DiabetesStatus unknownPhase 3Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y SaludNCT04222348Written as Insulin DetemirHow we know
- The Effect of Simple Basal Insulin Titration, Metformin Plus Liraglutide for Type 2 Diabetes With Very Elevated HbA1c - The SIMPLE StudyCompletedPhase 4University of Texas Southwestern Medical CenterNCT01966978Written as DetemirHow we know
- Efficacy and Safety of FIAsp Compared to Insulin Aspart Both in Combination With Insulin Detemir in Adults With Type 1 DiabetesCompletedPhase 3Novo Nordisk A/SNCT01831765Written as insulin detemirHow we know
- Safety and Efficacy of Inhaled Insulin in Type 1 DiabetesTerminatedPhase 3Novo Nordisk A/SNCT00322257Written as insulin detemirHow we know
- Sitagliptin in Non-Diabetic Patients Undergoing General SurgeryCompletedPhase 4Emory UniversityNCT02741687Written as Long acting basal insulin (insulin detemir)How we know
- Impact of Dietary Intervention on Weight Change in Subjects With Type 2 DiabetesCompletedPhase 4Novo Nordisk A/SNCT01232491Written as Insulin detemirHow we know
- Effect of Detemir and Sitagliptin on Blood Glucose Control in Type 2 DiabetesCompletedPhase 3Novo Nordisk A/SNCT00789191Written as insulin detemirHow we know
- The Effect of Insulin Detemir in Combination With Liraglutide and Metformin Compared to Liraglutide and Metformin in Subjects With Type 2 DiabetesCompletedPhase 3Novo Nordisk A/SNCT00856986Written as insulin detemirHow we know
- Safety and Efficacy of Inhaled Insulin in Type 2 DiabetesTerminatedPhase 3Novo Nordisk A/SNCT00331604Written as insulin detemirHow we know
- Efficacy and Safety of Basal-bolus Therapy, Comparing Stepwise Addition of Insulin Aspart Versus Complete Basal-bolus RegimenCompletedPhase 4Novo Nordisk A/SNCT01165684Written as insulin detemirHow we know
- A Study to Characterize Regimens of Basal Insulin Intensified With Either Symlin® or Rapid Acting Insulin in Patients With Type 2 DiabetesCompletedPhase 4AstraZenecaNCT00467649Written as basal insulin (Lantus® [insulin glargine], or Levemir® [insulin detemir])How we know
As the comparator · 17 — what is tested is compared with Insulin Detemir
- A Research Study of a New Medicine NNC0363-1063 in Healthy Participants and Participants With Type 1 DiabetesCompletedPhase 1Novo Nordisk A/SNCT06685185Written as Insulin detemirHow we know
- Research Study Comparing Insulin Degludec to Insulin Detemir, Together With Insulin Aspart, in Pregnant Women With Type 1 DiabetesCompletedPhase 3Novo Nordisk A/SNCT03377699Written as Insulin detemirHow we know
- A "Real World" Trial to Determine Efficacy and Health Outcomes of Toujeo Compared to "Standard of Care" Basal Insulins in Insulin Naïve Patients Initiating InsulinCompletedPhase 4SanofiNCT02967224Written as insulin detemirHow we know
- A "Real World" Trial to Determine Efficacy and Health Outcomes of Toujeo Compared to "Standard of Care" Basal Insulin in Patients Already Using Basal InsulinCompletedPhase 4SanofiNCT02967211Written as insulin detemirHow we know
- A "Real World" Trial to Determine Efficacy and Health Outcomes of Toujeo (ACHIEVE CONTROL REAL LIFE STUDY PROGRAM)CompletedPhase 4SanofiNCT02451137Written as Insulin detemirHow we know
- A Trial Investigating the Efficacy and Safety of Insulin Degludec/Insulin Aspart Once Daily Plus Insulin Aspart for the Remaining Meals Versus Insulin Detemir Once or Twice Daily Plus Meal Time Insulin Aspart in Children and Adolescents With Type 1 Diabetes MellitusCompletedPhase 3Novo Nordisk A/SNCT01835431Written as insulin detemirHow we know
- A Trial Investigating the Efficacy and Safety of Insulin Detemir Versus Insulin NPH in Combination With Metformin and Diet/Exercise in Children and Adolescents With Type 2 Diabetes Insufficiently Controlled on Metformin With or Without Other Oral Antidiabetic Drug(s) With or Without Basal InsulinTerminatedPhase 3Novo Nordisk A/SNCT02131272Written as Insulin detemirHow we know
- Comparison of NN5401 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 DiabetesCompletedPhase 3Novo Nordisk A/SNCT00978627Written as insulin detemirHow we know
- Comparison of NN1250 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 DiabetesCompletedPhase 3Novo Nordisk A/SNCT01074268Written as insulin detemirHow we know
- Comparison of NN1250 Versus Insulin Detemir, Both Combined With Insulin Aspart in Subjects With Type 1 DiabetesCompletedPhase 2Novo Nordisk A/SNCT00841087Written as insulin detemirHow we know
- The Effect of NN1250 in Subjects With Type 2 Diabetes of Different Race and/or Ethnic OriginCompletedPhase 1Novo Nordisk A/SNCT01043510Written as insulin detemirHow we know
- A Trial Investigating the Effect of NN1250 in Japanese Subjects With Type 1 DiabetesCompletedPhase 1Novo Nordisk A/SNCT01135927Written as insulin detemirHow we know
- Effect of a Basal/Pre-Meal Insulin Strategy (Detemir/Aspart) on Insulin Secretion and Action in Type 2 DiabetesCompletedPhase 4University of FloridaNCT00998335Written as Long-acting bedtime insulin detemir (Levemir)How we know
- Efficacy of Once-Weekly Exenatide Versus Once or Twice Daily Insulin Detemir in Patients With Type 2 DiabetesCompletedPhase 3AstraZenecaNCT01003184Written as insulin detemirHow we know
- Study on Liver Fat Content and Visceral Fat Mass in Overweight and Obese Type 2 Diabetes Patients After Treatment With Basal InsulinStatus unknownNot applicableFudan UniversityNCT01310452Written as insulin detemirHow we know
- Comparison of Two Basal Insulins for Patients With Type 2 Diabetes (IOOY)CompletedPhase 3Eli Lilly and CompanyNCT00494013Written as DetemirHow we know
- Lantus Versus Levemir Treat-To-TargetCompletedPhase 4SanofiNCT00405418Written as Insulin DetemirHow we know
Codes
What other systems call Insulin Detemir · ClinicalTrials.gg INT006564
- MeSH (NLM) D000069057Insulin DetemirConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 4FT78T86XVINSULIN DETEMIRConfirmed FDA, NLM, Wikidata
- RxNorm 139825Confirmed FDA, Wikidata
- Wikidata Q410965insulin detemirConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C65920Insulin DetemirConfirmed FDA, Wikidata
- DrugBank DB01307One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000069057 | Insulin Detemir | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 4FT78T86XV | INSULIN DETEMIR | Confirmed FDA, NLM, Wikidata |
| RxNorm | 139825 | — | Confirmed FDA, Wikidata |
| Wikidata | Q410965 | insulin detemir | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C65920 | Insulin Detemir | Confirmed FDA, Wikidata |
| DrugBank | DB01307 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.